Cambridge Investment Research Advisors, Inc. Schrodinger, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$53.75 - $76.55 $185,383 - $264,020	-3,449 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$59.02 - $78.8 $410,661 - $548,290	-6,958 Reduced 66.86%	3,449 $260,000
Q1 2021 May 07, 2021	BUY	$64.61 - $113.09 $458,343 - $802,260	7,094 Added 214.13%	10,407 $793,000
Q4 2020 Feb 04, 2021	BUY	$48.06 - $84.4 $159,222 - $279,617	3,313 New	3,313 $262,000

Others Institutions Holding SDGR

# of Institutions

236

Shares Held

61M

Call Options Held

726K

Put Options Held

329K

Black Rock Inc. New York, NY

8.52M
Shares

$187 Million
0.0% of portfolio
Bill Gates Bill & Melinda Gates Foundation Trust | Kirkland, Wa

6.98M
Shares

$154 Million
0.29% of portfolio
Vanguard Group Inc Valley Forge, PA

6.71M
Shares

$148 Million
0.0% of portfolio
Rubric Capital Management LP New York, NY

3.69M
Shares

$81.1 Million
1.9% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

2.34M
Shares

$51.4 Million
0.41% of portfolio

View Full List

About Schrodinger, Inc.

Ticker SDGR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 62,028,400
Market Cap $1.37B
Description
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...

More about SDGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account